Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.16% | $163.16M | $504.42B | 76.56% | 81 Outperform | |
| Roche Holding AG | 1.00% | $140.69M | CHF272.90B | 26.73% | 73 Outperform | |
| Shell | 0.85% | $120.45M | $234.58B | 26.82% | 78 Outperform | |
| HSBC Holdings | 0.82% | $116.39M | $284.16B | 44.81% | 78 Outperform | |
| Novartis | 0.68% | $96.56M | $299.88B | 38.55% | 80 Outperform | |
| AstraZeneca | 0.57% | $80.62M | $298.83B | 20.11% | 80 Outperform | |
| Toyota Motor | 0.56% | $79.00M | $288.71B | 15.23% | 81 Outperform | |
| SAFRAN SA | 0.56% | $78.93M | €132.45B | 23.86% | 67 Neutral | |
| BHP Group | 0.52% | $73.20M | $186.90B | 43.24% | 73 Outperform | |
| Agnico Eagle | 0.50% | $70.40M | $110.65B | 123.71% | 80 Outperform |